Medicines Development For Global Health

Medicines Development for Global Health develops medicines and vaccines for neglected diseases. Our approach is to bring together the ideas of researchers with our development expertise and passion to develop new products that will be life changing for millions. We are a non-profit company - all funds in excess of expenses are devoted to this purpose. In June 2018 we received FDA approval of moxidectin, the first new treatment for River Blindness in more than 20 years. Next we're turning our attention to seeing the benefit moxidectin might bring to other neglected tropical diseases and scabies. Medicines Development for Biotechnology provides development expertise to the small and medium bio-pharmaceutical industry. We specialize in providing the in-house clinical research team bringing instant industry expertise, standard operating procedures, and associated project management. Read more at medicinesdevelopment.com, and follow us on Twitter (@medicinesdev). Games to be changed. Much work to do. Sign up for our quarterly newsletter here: https://bit.ly/3mwzi0N